Facebook
Twitter
LinkedInThe Danish Cancer Institute
Scientific Director: Mads Melbye
The Danish Cancer Institute (DCI) is a cancer research institute within the Danish Cancer Society. It is in our DNA to focus our research on real-life problems by striving to reduce the risk of cancer, contribute to refined possibilities for early diagnostics and improve the life of cancer patients.
The Danish Cancer Society is Denmark’s largest NGO and dedicates more than 60% of the budget to research, with the remainder shared between information and patient support initiatives.
The DCI is uniquely positioned as a high-profile research center with strengths that build on excellent research, collaboration, curiosity and communication.
The DCI is an international research environment, aims to deliver cutting-edge research through synergy and strategic partnerships and has ambitious standards for career development and scientific outreach.
The DCI was founded based on strong research in basic biology and epidemiology. Today, these research directions have merged into a cross-collaborative cancer research center with an interdisciplinary and international research agenda.
Basic science is at the heart of the process that discovers new diagnostic and therapeutic possibilities. Epidemiologic research identifies the causes of cancer and describes the disease burden to contribute towards improving public health. Translational ambitions complement these areas of focus to enable the development of new strategies to prevent, diagnose and cure cancer.
Our Strategy Beyond 2020 describes our focus areas and the prioritized actions towards realizing our mission of impactful cancer research. Our way ahead defines four signature initiatives, i.e. impactful cancer research, translational ambitions and potential, a preferred environment for research training and partnering with patients and society.
Strong research profiles include:
- epidemiologic approaches to risk factors and geographical, socioeconomic, population group or cancer type specific disparities
- basic biology approaches to genomic integrity and repair, cell division, lysosome biology, and autophagy
- translational approaches to precision medicine and drug repurposing
- clinical interventions related to survivorship perspectives
The research at the Danish Cancer Institute is organized in 23 research groups and four core facilities. The institute is an international and multidisciplinary research environment with more than 250 researchers, students and technical personnel coming from more than 20 different countries and an annual research production of around 300 peer-reviewed publications.
You can read more about the research performed in our groups in their own presentations and in the DCI Research Report 2022
To all our donors – thank you for your contributions and for being part of this important work
